← Mechanisms of action
F7
SINGLE PROTEINHomo sapiens
Preferred name: Coagulation factor VII ChEMBL ↗
Linked proteins
Drugs acting on this target (15)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| hmb-001 | Binding agent | experimental | mAb | F7 binding agent |
| coagulation factor viia (recombinant) (NovoSevenRT) | Exogenous protein | approved | Recombinant protein | Coagulation factor VII exogenous protein |
| human factor ix complex (prothrombin complex concentrate) (Bebulin) | Exogenous protein | approved | Biological | Coagulation factor VII exogenous protein |
| mg1113 | Inhibitor | experimental | mAb | F7 inhibitor |
| pci-27483 | Inhibitor | experimental | Small molecule | Coagulation factor VII inhibitor |
| bay86-6150 | Supplementation | experimental | Recombinant protein | F7 supplementation |
| coagulation factor viia (recombinant) (NovoSevenRT) | Supplementation | approved | Recombinant protein | F7 supplementation |
| cor-1 | Supplementation | experimental | Peptide | F7 supplementation |
| csl689 | Supplementation | experimental | Recombinant protein | F7 supplementation |
| eptacog (Novoseven) | Supplementation | experimental | Biological | F7 supplementation |
| hi-con1 | Supplementation | experimental | Recombinant protein | F7 supplementation |
| marzaa | Supplementation | experimental | Recombinant protein | F7 supplementation |
| marzeptacog alpfa | Supplementation | experimental | Recombinant protein | F7 supplementation |
| mod-5014 | Supplementation | experimental | Recombinant protein | F7 supplementation |
| vatreptacog alfa (activated) | Supplementation | experimental | Recombinant protein | F7 supplementation |